Pharmaceutical giant Takeda has officially opened a new manufacturing plant at Grange Castle in Dublin that has already generated 40 jobs.

The new Takeda plant facilitates the production of an oncology treatment for global markets and puts drug substance, drug product, packaging, innovation and quality control all under one roof.

“We have built up a strong foundation in Ireland over the past 17 years, and this new plant in Grange Castle is an important strategic site for us, as it is not only the first overseas manufacturing centre for APIs outside of Japan, but it houses all the steps of the production process,” explained Takeda Pharmaceutical CEO Christophe Weber.

“Manufacturing excellence in pharmaceuticals is a hallmark of Ireland’s success in the sector”

“We are excited to take this next step and continue to deliver our medicines to patients around the world and concentrate our efforts on breakthrough innovations. I would like to thank our employees and stakeholders, as well as the IDA, for their support throughout the entire process.”

Chemical connection

Construction of the plant began in June 2017 and was managed by Project Management Group. A total of 40 jobs will be created at the site.

The plant is the first active pharmaceutical ingredient (API) manufacturing operation to be located outside of Japan for Takeda and houses all steps of the production process including API, drug product and primary and secondary packaging for supply to global markets.

“Manufacturing excellence in pharmaceuticals is a hallmark of Ireland’s success in the sector,” said IDA Ireland executive director Mary Buckley. “This innovative manufacturing site not only highlights Takeda’s commitment to Ireland, it also showcases how competitive Ireland is for global enterprise and investment.”

The Takeda Grange Castle plant currently employs over 80 people, all of whom are trained in the latest manufacturing techniques, to ensure operational excellence.

“I know from their investment in their facility in Dunboyne, in my local constituency, that they are a great employer and a significant player in the global pharmaceutical sector,” said the Minister for Employment Affairs and Social Protection, Regina Doherty, TD.

“This state-of-the-art manufacturing facility at Grange Castle is a great vote of confidence in Ireland and a very welcome development,” Doherty added.

Written by John Kennedy

Published: 5 July 2019

Pictured above: Takeda CEO Christophe Weber chatting with IDA Ireland executive director Mary Buckley and Business and Enterprise Minister Regina Doherty, TD. Image: Jason Clarke Photography

Recommended